Does India need the big vaccine bully?

By Maitri Porecha in BFO #313, 25 Jun, 21

It has been six months since India launched the Covid-19 vaccination drive, but it has not been able to achieve a middle ground with US-based pharmaceutical company Pfizer for getting at least 50 million doses into the country. 

The elephant in the room that both negotiating parties are not addressing openly is the clause for ‘indemnity.’ It is basically a contract by which Pfizer is asking the Indian government to protect the corporate giant from any legal claims that may occur if someone decides to sue the company, for possible vaccine-related side-effects.